These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23015686)

  • 21. Anhedonia, avolition, and anticipatory deficits: assessments in animals with relevance to the negative symptoms of schizophrenia.
    Barnes SA; Der-Avakian A; Markou A
    Eur Neuropsychopharmacol; 2014 May; 24(5):744-58. PubMed ID: 24183826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine.
    Schlagenhauf F; Juckel G; Koslowski M; Kahnt T; Knutson B; Dembler T; Kienast T; Gallinat J; Wrase J; Heinz A
    Psychopharmacology (Berl); 2008 Mar; 196(4):673-84. PubMed ID: 18097655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anhedonia, self-experience in schizophrenia, and implications for treatment.
    Juckel G; Sass L; Heinz A
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S176-80. PubMed ID: 14677076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticipatory pleasure and approach motivation in schizophrenia-like negative symptoms.
    Engel M; Fritzsche A; Lincoln TM
    Psychiatry Res; 2013 Dec; 210(2):422-6. PubMed ID: 23928213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anhedonia in Schizophrenia.
    Moran EK; Culbreth AJ; Barch DM
    Curr Top Behav Neurosci; 2022; 58():129-145. PubMed ID: 35503596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired Expected Value Computations in Schizophrenia Are Associated With a Reduced Ability to Integrate Reward Probability and Magnitude of Recent Outcomes.
    Hernaus D; Frank MJ; Brown EC; Brown JK; Gold JM; Waltz JA
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Mar; 4(3):280-290. PubMed ID: 30683607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From neuroimaging to daily functioning: A multimethod analysis of reward anticipation in people with schizophrenia.
    Moran EK; Culbreth AJ; Kandala S; Barch DM
    J Abnorm Psychol; 2019 Oct; 128(7):723-734. PubMed ID: 31464449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticipation: An Essential Feature of Anhedonia.
    Phillips AG; Ahn S
    Curr Top Behav Neurosci; 2022; 58():305-323. PubMed ID: 35435641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered cingulo-striatal function underlies reward drive deficits in schizophrenia.
    Park IH; Chun JW; Park HJ; Koo MS; Park S; Kim SH; Kim JJ
    Schizophr Res; 2015 Feb; 161(2-3):229-36. PubMed ID: 25468177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Motivation deficits in individuals with social anhedonia.
    Wang J; Huang J; Lui SSY; Cheung EFC; Yue XD; Chan RCK
    Psychiatry Res; 2018 Mar; 261():527-534. PubMed ID: 29395876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Psychopathological correlates of dopaminergic dysfunction in alcoholic and schizophrenic patients].
    Heinz A
    Nervenarzt; 1999 May; 70(5):399-407. PubMed ID: 10407835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia.
    Eisenstein SA; Bogdan R; Chen L; Moerlein SM; Black KJ; Perlmutter JS; Hershey T; Barch DM
    J Psychiatr Res; 2017 Mar; 86():9-17. PubMed ID: 27886638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs.
    Kring AM; Barch DM
    Eur Neuropsychopharmacol; 2014 May; 24(5):725-36. PubMed ID: 24461724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal Frontostriatal Activity During Unexpected Reward Receipt in Depression and Schizophrenia: Relationship to Anhedonia.
    Segarra N; Metastasio A; Ziauddeen H; Spencer J; Reinders NR; Dudas RB; Arrondo G; Robbins TW; Clark L; Fletcher PC; Murray GK
    Neuropsychopharmacology; 2016 Jul; 41(8):2001-10. PubMed ID: 26708106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine and reward: the anhedonia hypothesis 30 years on.
    Wise RA
    Neurotox Res; 2008 Oct; 14(2-3):169-83. PubMed ID: 19073424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced neural activity when anticipating social versus nonsocial rewards in schizophrenia: Preliminary evidence from an ERP study.
    Catalano LT; Wynn JK; Green MF; Gold JM
    Schizophr Res; 2022 Aug; 246():7-16. PubMed ID: 35696860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased dopamine D2 receptor activity in the striatum alters the firing pattern of dopamine neurons in the ventral tegmental area.
    Krabbe S; Duda J; Schiemann J; Poetschke C; Schneider G; Kandel ER; Liss B; Roeper J; Simpson EH
    Proc Natl Acad Sci U S A; 2015 Mar; 112(12):E1498-506. PubMed ID: 25675529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frontal-striatum dysfunction during reward processing: Relationships to amotivation in schizophrenia.
    Chung YS; Barch DM
    J Abnorm Psychol; 2016 Apr; 125(3):453-469. PubMed ID: 26845257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Striatal response to reward anticipation: evidence for a systems-level intermediate phenotype for schizophrenia.
    Grimm O; Heinz A; Walter H; Kirsch P; Erk S; Haddad L; Plichta MM; Romanczuk-Seiferth N; Pöhland L; Mohnke S; Mühleisen TW; Mattheisen M; Witt SH; Schäfer A; Cichon S; Nöthen M; Rietschel M; Tost H; Meyer-Lindenberg A
    JAMA Psychiatry; 2014 May; 71(5):531-9. PubMed ID: 24622944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motivational Deficits in Schizophrenia and the Representation of Expected Value.
    Waltz JA; Gold JM
    Curr Top Behav Neurosci; 2016; 27():375-410. PubMed ID: 26370946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.